Said Samih Taleb Darwazah (born 1957) is a Jordanian heir and business executive. He serves as the chairman and chief executive officer (CEO) of Hikma Pharmaceuticals, the FTSE 100 multinational generic pharmaceutical manufacturer founded by his father.
Said Darwazah | |
|---|---|
| Born | Said Samih Taleb Darwazah May 1957 (age 67) |
| Nationality | Jordanian |
| Alma mater | Purdue University INSEAD |
| Occupation(s) | Chairman and CEO, Hikma Pharmaceuticals |
| Parent | Samih Darwazah |
Darwazah was born in May 1957,[1] the son of Samih Darwazah, the founder of Hikma Pharmaceuticals, which he joined in 1980.[2] He has a bachelor's degree in Industrial Engineering from Purdue University in the US, and an MBA from INSEAD.[3] Darwazah was appointed CEO in July 2007, and chairman in May 2014.[4]
References
edit- ^ "Hikma Pharmaceuticals plc". Companies House. Retrieved 12 September 2015.
- ^ "Said S. Darwazah". Purdue University. Retrieved 26 March 2020.
- ^ "Executive Profile* Said Samih Taleb Darwazah". Bloomberg. Retrieved 12 September 2015.
- ^ "Our management". Hikma. Archived from the original on 15 November 2015. Retrieved 12 September 2015.